This is a phase 1 trial, consisting of an initial open-label sentinel run-in (n=25) phase and a randomized, double-blind, dose-finding trial (n=125) in flavivirus naΓ―ve adults aged 18 to 49 years. In total Ò€¦ In november 2025 positive results of its phase 1 clinical trial investigating the safety and immunogenicity of vla1601 were announced.

Several new strategies are under investigation for vaccines, monoclonal antibodies, and serological tests with improved specificity, including multiplex and point-of-care diagnostics.

πŸ“– Continue Reading:

Esther Abrami Nude Jersey Jess Nude